Month: March 2022

Categories
Pharmaceutical

North America is the Most Dominant Region that Holds Over 3/4 of the Global Pegfilgrastim Biosimilar Market Share – Fact.MR Study

According to Fact MR’s recent market research, sales of Pegfilgrastim Biosimilar to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges.

It also provides recommendations to assist businesses in preparing for unforeseen challenges. Focus on improving overall patient care will remain a chief growth driver. Besides this, Pegfilgrastim Biosimilar market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=1494

Pegfilgrastim is developed by PEGylating the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. Pegfilgrastim was first launched by Amgen Inc. as Neulasta in 2002. Later, several biosimilars of pegfilgrastim were launched in the market.

Pegfilgrastim is used as a supportive oncology drug to treat chemotherapy- and/or radiotherapy-induced neutropenia in cancer patients. With more than ten pegfilgrastim biosimilars available in the market and over 5 under development, the pegfilgrastim biosimilar size market is expected to witness an upswing in the future.

The COVID-19 pandemic effect has been moderate on the overall pegfilgrastim market. COVID-19 has overall affected the speed of processes in clinical trials, but it’s predicted that, there will not be any near-term effect on approval processes by the regulatory bodies.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Pegfilgrastim Biosimilar market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Pegfilgrastim Biosimilar

The report offers actionable and valuable market insights of Pegfilgrastim Biosimilar. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Pegfilgrastim Biosimilar Market across various industries and regions.

pegfilgrastim biosimilar market

This newly published and insightful report sheds light on Market Insights of Pegfilgrastim Biosimilar, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Pegfilgrastim Biosimilar Market.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=1494

Key Segments of Pegfilgrastim Biosimilar Market

Fact.MR’s study on the pegfilgrastim biosimilar market offers information divided into two important segments-distribution channel and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories, for the better understanding of readers.

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail-Order Pharmacies

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/1494

Key Takeaways from Pegfilgrastim Biosimilar Market Study

  • The hospital pharmacies segment under the distribution channel category held half of the global pegfilgrastim biosimilar market share in 2019, owing to increasing cancer treatments such as chemotherapy and others. Retail pharmacies followed due to increasing number of prescriptions.
  • North America holds almost 3/4 of the global pegfilgrastim biosimilar market, followed by Europe, owing to large number of product launches in these regions.
  • The East Asia market year-on-year growth is expected to rapidly surge in the near future. This growth is due to increasing pool of patients and advancements in healthcare with government support, which will propel pegfilgrastim biosimilar market growth in Asian countries.
  • The COVID-19 pandemic that has swept the world is projected to have only a moderate impact on the progress of the pegfilgrastim biosimilar market.

“Increasing demand for cost-effective therapeutics such as biosimilars and patent expiration of blockbuster biologics will provide competitive benefits to market players in terms of new product development,” says a Fact.MR analyst.

Pegfilgrastim Biosimilar Market: Key Players

The pegfilgrastim biosimilar market is significantly consolidated and competitive in nature. Many small and large pharmaceutical companies have developed this biosimilar. Key players operating in the market are Coherus Biosciences, Mylan N.V., Biocon, and Novartis AG (Sandoz). These companies have launched pegfilgrastim biosimilars and are bolstered with partnerships and collaborations for expanding their market presence, globally.

Other players in the market are Pfizer Inc, Green Cross Corp, Accord healthcare, Intas Pharmaceuticals Ltd, and Zydus Cadila. These players are focused on strategic collaborations & partnerships and investments in research & development for developing novel biosimilar platforms.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Pegfilgrastim Biosimilar Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Pegfilgrastim Biosimilar Historical volume analysis: The report provides a comparison of Pegfilgrastim Biosimilar’s historical sales and projected sales performance for 2021-2031.
  • Pegfilgrastim Biosimilar Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Pegfilgrastim Biosimilar market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Pegfilgrastim Biosimilar Consumption by demographics: The report investigates consumer behavior affecting Pegfilgrastim Biosimilar demand outlook for the assessment period. Effect of their keenness for digital trends on Pegfilgrastim Biosimilar market is carefully analyzed
  • Post COVID consumer spending on Pegfilgrastim Biosimilar: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Pegfilgrastim Biosimilar market growth.

More Valuable Insights on Pegfilgrastim Biosimilar Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Pegfilgrastim Biosimilar, Sales and Demand of Pegfilgrastim Biosimilar, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

North America is Expected to be the Most Lucrative Market for Medical Case Management Service – Fact.MR Study

250 Pages Medical Case Management Service Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Medical Case Management Service to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Medical Case Management Service market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=74

Fact.MR, market research and competitive intelligence provider has recently released its revised analysis on the global medical case management service market. The analysts have predicted the industry to expand at a stagnant CAGR of around 3.2% over the decade. The market valuation which is expected to be US$ 4 Bn by the end of 2021 and is predicted to rise 1.3X by the end of decade.

CAGR 3.2% (2021-2031)
Global Market Value in 2021 US$ 4 Bn
Projected Market Value for 2031 US$ 5.5 Bn

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Medical Case Management Service market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Medical Case Management Service

Medical case management service market regional analysis by Fact.MR

The report offers actionable and valuable market insights of Medical Case Management Service. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Medical Case Management Service Market across various industries and regions

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=74

Key Segments of Medical Case Management Service Industry Survey

  • By Mode of Service:

    • Web-based Case Management Services
    • Telephonic Case Management Services
    • Field Case Management Services
    • Bilingual Field Case Management Services
    • Other Services

  • By End User:

    • Medical Case Management Services for Hospitals
    • Medical Case Management Services for Homecare Settings

  • By Severity of Case:

    • Catastrophic Case Medical Management Services
    • Chronic Pain Case Medical Management Services
    • Independent Medical Examinations
    • Short-term Disability
    • Long-term Disability

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/74

Key Takeaways from Market Study

  • Medical case management service market revenue estimated to attain a valuation of US$ 5.5 Bn by 2031.
  • Industry expected to rise at steady CAGR of 3.2% over next ten years.
  • Developed regions such as North America and Europe expected to see substantial rise in adoption of medical case management services.
  • Market growth in emerging economies expected to be hindered by lack of awareness.
  • Rising healthcare expenditure, increasing instances of diseases, growing complexity of healthcare systems, and ability to reduce healthcare costs are some of the major factors that drive demand for medical case management services.

“Efforts in increasing awareness across emerging economies and less developed regions should prove beneficial for medical case management service providers,” says a Fact.MR analyst.

Competitive Landscape

Some of the key providers of medical case management services, such as GENEX Services Inc., EagleOne Case Management Solutions Inc., EK Health Services Inc., Healthcare Solutions Inc., Europ Assistance – Global Corporate Solutions, Precyse Solutions LLC., Axiom Medical Consulting LLC, Managed Medical Review Organization Inc., and Medical Case Management Group., have been profiled in this market study.

  • Somatus, in October 2021, was awarded NCQA accreditation for population health as well as case management. Somatus has now become the first-of-its-kind kidney care management provider.
  • In July 2021, Remote Medical International announced the launch of its case management services along with the RMI Access Telemedicine service.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Medical Case Management Service Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Medical Case Management Service Historical volume analysis: The report provides a comparison of Medical Case Management Service’s historical sales and projected sales performance for 2021-2031.
  • Medical Case Management Service Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Medical Case Management Service market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Medical Case Management Service Consumption by demographics: The report investigates consumer behavior affecting Medical Case Management Service demand outlook for the assessment period. Effect of their keenness for digital trends on Medical Case Management Service market is carefully analyzed
  • Post COVID consumer spending on Medical Case Management Service: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Medical Case Management Service market growth.

More Valuable Insights on Medical Case Management Service Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Medical Case Management Service, Sales and Demand of Medical Case Management Service, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

 

Categories
Pharmaceutical

High Prevalence of Adenocarcinoma Enables Growth in Prostate Cancer Treatment Market – Fact.MR Study

250 Pages Prostate Cancer Treatment Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Prostate Cancer Treatment to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Prostate Cancer Treatment market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=58

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Prostate Cancer Treatment market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Prostate Cancer Treatment

According to Fact.MR, the global market for Prostate Cancer Treatment was valued at around US$ 3 Bn in 2020 and is projected to expand at a staggering CAGR of over 10% through 2031. The market is expected to surpass a staggering value of US$ 8 Bn by 2031.

The report offers actionable and valuable market insights of Prostate Cancer Treatment. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Prostate Cancer Treatment Market across various industries and regions

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=58

Key Segments Covered

  • Test Type

    • PSA Prostate Cancer Diagnostic Tests
    • PCA3 Prostate Cancer Diagnostic Test
    • CTC  Prostate Cancer Diagnostic Tests
    • Immunohistochemistry Prostate Cancer Diagnostic Test

  • By End User

    • Prostate Cancer Diagnostics in Hospitals
    • Prostate Cancer Diagnostics in Independent Diagnostic Laboratories
    • Prostate Cancer Diagnostics in Cancer Research Institutes
    • Prostate Cancer Diagnostics in Other Settings

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/58

Key Takeaway from the Market Study

  • By test type, PSA tests likely to surpass US$ 270 Mn in value by 2021-end
  • Demand for PCA-3 tests to soar, expected to exceed a valuation of US$ 284 Mn by 2031
  • CTC tests acquiring popularity, poised to surpass US$ 141 Mn by 2021-end
  • Diagnostic tests across hospitals and research institutes to collectively expand at 15% CAGR
  • U.S to emerge as an opportunistic market, registering a CAGR of around 9%
  • China to generate 40% demand for prostate cancer diagnostics across East Asia

“Changing lifestyles, awareness regarding prostate cancer and use of artificial intelligence for prostate cancer diagnostics are expected to uplift demand for prostate cancer diagnostics in coming years.” comments the Fact.MR analyst.

Competitive Landscape

Prominent prostate cancer diagnostics providers include Abbott Laboratories, AstraZeneca Plc., Danaher Corporation, Vyant Bio Inc., Biocept Inc., Becton Dickinson & Company, Agilent Technologies and Myriad Genetics Inc. to name a few.

  • In June 2021, Biocept Inc. was awarded a South Korean patent for its Primer-Switch technology, which detects rare mutations in circulating tumor DNA (ctDNA) using RT-PCR. This patent is titled Methods for Detecting Nucleic Acid Sequence Variants
  • Likewise, in March 2021, Myriad Genetics joined forces with Intermountain Precision Genomics for a comprehensive offering of germline and somatic tumor testing services for detecting advanced hereditary cancers, including prostate cancer

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Prostate Cancer Treatment Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Prostate Cancer Treatment Historical volume analysis: The report provides a comparison of Prostate Cancer Treatment’s historical sales and projected sales performance for 2021-2031.
  • Prostate Cancer Treatment Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Prostate Cancer Treatment market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Prostate Cancer Treatment Consumption by demographics: The report investigates consumer behavior affecting Prostate Cancer Treatment demand outlook for the assessment period. Effect of their keenness for digital trends on Prostate Cancer Treatment market is carefully analyzed
  • Post COVID consumer spending on Prostate Cancer Treatment: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Prostate Cancer Treatment market growth.

More Valuable Insights on Prostate Cancer Treatment Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Prostate Cancer Treatment, Sales and Demand of Prostate Cancer Treatment, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Drug Discovery Services Market: Hit-To-Lead Identification to Gain Maximum Traction – Fact.MR Study

250 Pages Drug Discovery Services Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Drug Discovery Services to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Drug Discovery Services market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=375

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Drug Discovery Services market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Drug Discovery Services

Increase in the research and development activities and expenditure, leading pharmaceutical companies moving towards outsourcing are some of the factors resulting in the growth of drug discovery services.

Introduction of advanced technology in the drug discovery process is also the major driver in the market growth. However, stringent regulations in some regions on drug discovery services, high cost involved in the discovery of drug and development and usage of animals in testing are hampering the market growth.

The report offers actionable and valuable market insights of Drug Discovery Services. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Drug Discovery Services Market across various industries and regions

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=375 

Market Taxonomy

Process
  • Target Selection
  • Target Validation
  • Hit-To-Lead Identification
  • Lead Optimization
  • Candidate Validation
Type
  • Medicinal Chemistry
  • Biology Services
  • Drug Metabolism and Pharmacokinetics
Drug Type
  • Small Molecules
  • Biologics
Therapeutic Area
  • Oncology
  • Neurology
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Diabetes
  • Other Therapeutic Areas

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/375 

6 Key Insights on Global Drug Discovery Services Market

  • North America is likely to remain dominant in the global drug discovery services market throughout the forecast period 2017-2026. Presence of leading pharmaceutical companies in the region is one of the factors driving the growth of drug discovery services in North America.
  • Asia Pacific Excluding Japan (APEJ) is also anticipated to witness significant growth during 2017-2026. India and China are slowly becoming preferred locations for drug discovery outsourcing due to the technological capabilities developed. Fewer regulations and low manufacturing costs are also fueling the growth in APEJ region.
  • Hit-To-Lead identification is likely to be the most preferred process in the global drug discovery services market. By the end of 2026, hit-to-lead identification is projected to reach nearly US$ 7,000 million revenue.
  • By drug discovery service type, medicinal chemistry is likely to witness the significant growth. Towards the end of 2026, medicinal chemistry is projected to surpass US$ 6,000 million revenue.
  • Small molecules are anticipated to be the largest drug type in the global drug discovery service market. Small molecules are projected to create an incremental opportunity of more than US$ 5,800 million between 2017 and 2026.
  • On the basis of therapeutic area, highest growth is expected to be seen in oncology. Oncology is projected to reach nearly US$ 7,000 million revenue towards the end of 2026.

The report offers a profile of some prominent players in the global drug discovery services market, which will stay active through 2026. The leading companies are Thermo Fisher Scientific, Inc., Merck Millipore, GE Healthcare, Albany Molecular Research, Inc. (AMRI), Charles River Laboratories International, Evotec, Pharmaceutical Product Development, LLC. (Ppd), Covance, Jubilant Biosys, Genscript Biotech Corporation, Aurigene Discovery Technologies, Wuxi Apptec, and Syngene.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Drug Discovery Services Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Drug Discovery Services Historical volume analysis: The report provides a comparison of Drug Discovery Services’s historical sales and projected sales performance for 2021-2031.
  • Drug Discovery Services Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Drug Discovery Services market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Drug Discovery Services Consumption by demographics: The report investigates consumer behavior affecting Drug Discovery Services demand outlook for the assessment period. Effect of their keenness for digital trends on Drug Discovery Services market is carefully analyzed
  • Post COVID consumer spending on Drug Discovery Services: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Drug Discovery Services market growth.

More Valuable Insights on Drug Discovery Services Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Drug Discovery Services, Sales and Demand of Drug Discovery Services, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Melanoma Cancer Diagnostics Market: Non-Invasive Techniques Show Promising Results in Skin Cancer Diagnostics – Fact.MR Study

250 Pages Melanoma Cancer Diagnostics Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Melanoma Cancer Diagnostics to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Melanoma Cancer Diagnostics market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=57

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Melanoma Cancer Diagnostics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Melanoma Cancer Diagnostics

The report offers actionable and valuable market insights of Melanoma Cancer Diagnostics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Melanoma Cancer Diagnostics Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Melanoma Cancer Diagnostics, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Melanoma Cancer Diagnostics Market.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=57

Market Structure

Segment-wise analysis of the melanoma cancer diagnostics is highlighted in the report to identify and provide details on the existing market opportunities.

The melanoma cancer diagnostics market is segmented on the basis of test type and end user.

These segments are further divided into sub-segments to offer better understanding of melanoma cancer diagnostics market.

Based on the test type, the melanoma cancer diagnostics market is segmented into Fluorescent in Situ Hybridization (FISH) Tests, Immunohistochemical (IHC) Tests, and Comparative Genomic Hybridization (CGH) Tests.

On the basis of end-user, the melanoma cancer diagnostics market is segmented into Pathology Laboratories, Hospitals, and Cancer Research Centres.

Governments Initiatives for Early Detection and Skin Cancer Treatment Drive Adoption

With a rise in melanoma related deaths across various countries, melanoma diagnostics and therapeutics is significantly increasing.

Government initiatives, along with the advancement in technology is also driving the growth of melanoma cancer diagnostics. Notable initiatives include,

  • European Skin Care Foundation (ESCF) is strongly focusing on establishing skin cancer centers across Europe. ESCF is also supporting research activities with an emphasis on innovative modalities for diagnosis and treatment.
  • To effectively manage melanoma in New Zealand and Australia, initiatives have been taken by governments in both the countries for early detection and holistic treatment. The Ministry of Health in New Zealand has established National Cancer Program to provide high quality and timely treatment for cancer.
  • The Ministry of Health in New Zealand, in partnership with various institutions, is likely to hold cancer control conference in 2019 to discuss major challenges and identify possible solutions.
  • The Department of Health in Australia review of evidence on effectiveness of public awareness campaigns to increase awareness for need of skin checks among people, with strategies to target high risk groups.

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/57

According to a latest market research by fast-growing market research and consulting firm, the global melanoma cancer diagnostics market is poised to grow at over 7% CAGR and surpass US$ 853.5 million in revenues by 2022. Fact.MR’s report forecasts that North America and Europe will remain the most lucrative markets for melanoma cancer diagnostics market globally. Key takeaways from Fact.MR’s report are,

  • The U.S. melanoma cancer diagnostics market will grow at over 7% CAGR and reach US$ 409.2 Mn by 2022. By test type, BRAF mutation segment will continue to be the leading segment.
  • Germany is one of the largest markets for melanoma cancer diagnostics in Europe. Fact.MR projects the Germany melanoma cancer diagnostics market to grow at 7.4% CAGR through 2022. Hospital associated labs are the largest end-users of melanoma cancer diagnostics in Germany. The market in United Kingdom will grow at a higher rate than Germany, but it will be continue to be smaller in market size.
  • The market will be positive influenced by increasing R&D on cancer diagnosis and management. Increasing prevalence of melanoma and effective immunotherapies are expected to drive growth of the market globally.
  • Although the outlook on the global melanoma cancer diagnostics market is positive, limited funds in emerging countries, combined with challenges surrounding regulatory issues can stymie growth during the forecast period.
  • By test type, BRAF mutation segment will account for a significant share of global revenues. This test type will continue to be used widely in major markets of North America and Europe. The CTC segment, on the other hand, is projected to grow at a higher CAGR than BRAF segment. Immunohistochemistry, another test type, is projected to grow at over 6% CAGR in the global melanoma cancer diagnostics market.
  • The key end-use segments of the global melanoma cancer diagnostics market have been identified as hospital associated labs, cancer research institutes, and independent diagnostic laboratories. Among these, the hospital associated labs end-use segment is the most prominent globally. According to Fact.MR’s research, hospital associated labs will remain the largest end-users for melanoma cancer diagnostics market during the forecast period.
  • Demand is also expected to remain steady from independent diagnostic laboratories segment. In North America, demand from this segment is expected to surpass US$ 100 million by 2022. The trend will also remain strong in Europe, with this segment growing at nearly 8% CAGR during the forecast period.
  • Leading companies profiled in the report include Cancer Genetics, Inc., Myriad Genetics Inc. Abbott Laboratories, Foundation Medicine, Inc., and Pathway Genomics Corporation

Read More Trending Reports of Fact.MR-
https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Melanoma Cancer Diagnostics Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Melanoma Cancer Diagnostics Historical volume analysis: The report provides a comparison of Melanoma Cancer Diagnostics’s historical sales and projected sales performance for 2021-2031.
  • Melanoma Cancer Diagnostics Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Melanoma Cancer Diagnostics market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Melanoma Cancer Diagnostics Consumption by demographics: The report investigates consumer behavior affecting Melanoma Cancer Diagnostics demand outlook for the assessment period. Effect of their keenness for digital trends on Melanoma Cancer Diagnostics market is carefully analyzed
  • Post COVID consumer spending on Melanoma Cancer Diagnostics: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Melanoma Cancer Diagnostics market growth.

More Valuable Insights on Melanoma Cancer Diagnostics Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Melanoma Cancer Diagnostics, Sales and Demand of Melanoma Cancer Diagnostics, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Biologics Drugs and PDE4 Inhibitors Account for Major Chunk of Atopic Dermatitis Market Share – Fact.MR Study

250 Pages Atopic Dermatitis Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Atopic Dermatitis to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Atopic Dermatitis market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=4603

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Atopic Dermatitis market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Atopic Dermatitis

The report offers actionable and valuable market insights of Atopic Dermatitis. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Atopic Dermatitis Market across various industries and regions.

atopic dermatitis market 02

This newly published and insightful report sheds light on Market Insights of Atopic Dermatitis, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Atopic Dermatitis Market.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4603

Global Atopic Dermatitis Drugs Market Segmentation

Fact.MR has studied the global atopic dermatitis drugs market with detailed segmentation on the basis product type, application and key regions.

Drug Class
  • Corticosteroids
  • PDE4 Inhibitors
  • Biologics
  • Skin Barrier Emollients
  • CNI Immunosuppressants
  • Others
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Key Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared.

Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4603

Key Takeaways of Global Atopic Dermatitis Drugs Market Study

  • Biologics Drugs is the leading segment by drug class. Projected CAGR for the same is pegged at a staggering CAGR of 32.1% during the forecast period. New product launches and increased adoption of Biologics drugs are key factors driving the growth of the segment.
  • PDE4 Inhibitors closely follow the biologics drugs segment, registering a whopping CAGR of 31.1%. Increased affordability of treatment and intensive research and development are expected to drive the growth of PDE4 Inhibitors.
  • Retail Pharmacies are expected to account for three-fourth of the market share for atopic dermatitis drugs. Increased number of retail pharmacies, easy availability of therapeutic drugs and convenience are some contributing factors.
  • North America shall retain its dominance in the atopic dermatitis drugs market. Adoption of advanced biologics drugs, adequate reimbursement coverage for pharmaceutical companies and greater market penetration of new players are some major growth stimulators. The region is set to expand at a CAGR of 27% during the forecast period.
  • Europe is the second most attractive market, accounting for around one-third of the global atopic dermatitis drugs market. This is due to increased awareness about the disease, favorable medical reimbursement policies and well-established healthcare facilities.

“The global atopic dermatitis drugs market demonstrates exceptional potential in the future. Increasing incidence of dermatological disorders, combined with intensive research and development in novel pipeline drugs, is expected to propel market share,” concludes a Fact.MR analyst

Development of Novel Drugs to Determine Market Competitiveness

Investments in development of novel pipeline drugs is expected to shape the global atopic dermatitis drugs market competitiveness. An example for this is the development of the biologics drug DUPIXNET ® by Sanofi Genzyme, which cures skin lesions and reduces itching. It does so by inhibiting secretions of interleukin-4 (IL-4) and interleukin-13 (IL-13) protein strains, responsible for type 2 skin inflammation. Likewise, Eucrisa (crisaborole), developed by Pfizer, Inc., consists of PDE4 Inhibitors to treat skin ailments like Eczema. It works by controlling the over-reactive parts of the PDE4 enzyme within skin cells to prevent inflammation.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Atopic Dermatitis Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Atopic Dermatitis Historical volume analysis: The report provides a comparison of Atopic Dermatitis’s historical sales and projected sales performance for 2021-2031.
  • Atopic Dermatitis Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Atopic Dermatitis market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Atopic Dermatitis Consumption by demographics: The report investigates consumer behavior affecting Atopic Dermatitis demand outlook for the assessment period. Effect of their keenness for digital trends on Atopic Dermatitis market is carefully analyzed
  • Post COVID consumer spending on Atopic Dermatitis: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Atopic Dermatitis market growth.

More Valuable Insights on Atopic Dermatitis Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Atopic Dermatitis, Sales and Demand of Atopic Dermatitis, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

 

Categories
Pharmaceutical

Preimplantation Genetic Testing Market Is Projected To Grow At Nearly 9% CAGR Through 2031

Preimplantation Genetic Testing Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations  for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Preimplantation Genetic Testing insightful data for the specific country/regions.

The country specific data is again analyzed to derive data at a global level. Specific factors/parameters are considered related to the individual Preimplantation Genetic Testing market and quantified with insightful rationale.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=292

The Market survey of Preimplantation Genetic Testing offers a comprehensive analysis of diverse features, including production capacities analysis of Preimplantation Genetic Testing, demand, product developments, revenue generation, and Size of Preimplantation Genetic Testing Market across the globe.

Key Segments Covered

  • Test Type
    • Preimplantation Genetic Diagnostics
    • Preimplantation Genetic Screening
  • End User
    • Preimplantation Genetic Testing in Hospitals
    • Preimplantation Genetic Testing in Diagnostic Labs
    • Preimplantation Genetic Testing in Research & Academic Institutions
    • Preimplantation Genetic Testing in Specialized Clinics
    • Preimplantation Genetic Testing by Other End Users
  • Application
    • Preimplantation Genetic Testing for Embryo HLA Typing for Stem Cell Therapy
    • Preimplantation Genetic Testing for IVF Prognosis
    • Preimplantation Genetic Testing for Late-Onset Genetic Disorders
    • Preimplantation Genetic Testing for Inherited Genetic Diseases
    • Preimplantation Genetic Testing for Other Applications
  • Technology
    • NGS-based Preimplantation Genetic Testing
    • PCR-based Preimplantation Genetic Testing
    • FISH-based Preimplantation Genetic Testing
    • CGH-based Preimplantation Genetic Testing
    • SNP-based Preimplantation Genetic Testing

Key Parameters analyzed while estimating the Preimplantation Genetic Testing market include:

  • To analyze Drugs/ Therapeutic Area in Preimplantation Genetic Testing :

Overall Population by age group/Prevalence or Incidence of any disease/Treatment Seeking Rate/Dosage pattern/Average duration of treatment/Overall treatment cost and Reimbursement are considered.

  • To analyze Consumables of Preimplantation Genetic Testing:

Overall Population/Prevalence or Incidence of disease/treatment seeking rate/ average duration of the treatment/average number of devices used per patient / average number of procedure per device/ average selling price per device/reimbursement are considered.

  • To analyze Preimplantation Genetic Testing Equipment:

Number of Healthcare facilities (Hospitals/Ambulatory Surgical Centers/Clinics etc.)

Average number of devices installed per facilities/ lifespan of the devices/replacement rate of the equipment/new sales of the equipment per year/average selling price per equipment are considered.

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=292

Some Notable Offerings by Fact.MR Report on Preimplantation Genetic Testing market:

  • We will provide you an analysis of the extent to which this Preimplantation Genetic Testing market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
  • We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
  • Also, this report will help you to identify any trends to forecast growth rates.
  • The analyzed report will forecast the general tendency for supply and demand.

Competitive Landscape

Preimplantation genetic testing market is a highly consolidated market in which a small group of players accounts for near half of the global sales.

In May 2021, United Airlines and Abbott Laboratories announced a collaboration to use Abbott’s BinaxNOW™ COVID-19 Home Test and Abbott’s NAVICA app to help make the international travel experience more seamless.

The CDC guidelines permit travelers to self-administer a rapid antigen test under the real-time supervision of a telehealth service and use the verified negative test result to board an international flight to the U.S. if they test negative.

To get all-in insights on the regional landscape of the Preimplantation Genetic Testing Market, buy now:-https://www.factmr.com/checkout/292

After reading the Market insights of Preimplantation Genetic Testing Report, readers can:

  • Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
  • Analyze key regions holding significant share of total Preimplantation Genetic Testing market revenue.
  • Study the growth outlook of Preimplantation Genetic Testing market scenario, including production, consumption, history and forecast.
  • Learn consumption pattern and impact of each end use & supply side analysis of Preimplantation Genetic Testing market.
  • Investigate the recent R&D projects performed by each market player & competitive analysis of Preimplantation Genetic Testing Market Players.

How Fact.MR Assists in Making Strategic Moves For Preimplantation Genetic Testing Market Manufacturer?

  • The data provided in the Preimplantation Genetic Testing market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
  • The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

For More Insights- https://www.einpresswire.com/article/556509410/demand-from-personal-care-cosmetic-products-to-drive-the-growth-of-solid-sericin-in-skincare

About Fact.MR:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

4-1-1 Nakano,
9F Nakano Sunplaza
Tokyo, 164-8512
Japan

Tel: +1 (888) 863-5616

Categories
Pharmaceutical

Global Platelet-Rich Plasma Market To Surpass A Value Of Around US$ 1.5 Bn By 2031

Platelet-Rich Plasma Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations  for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Platelet-Rich Plasma insightful data for the specific country/regions. The country specific data is again analyzed to derive data at a global level. Specific factors/parameters are considered related to the individual Platelet-Rich Plasma market and quantified with insightful rationale.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=170

Key Segments Covered

  • Product Type

    • Platelet-Rich Plasma Instruments
    • Pure Platelet-Rich Plasma Kits
    • Leucocyte-Rich Platelet-Rich Plasma Kits
    • Platelet-Rich Fibrin Kits
    • Pure Platelet-Rich Fibrin Kits

  • Application

    • Platelet-Rich Plasma for Orthopedic Surgery
    • Platelet-Rich Plasma for Cosmetic Surgery
    • Platelet-Rich Plasma for General Surgery
    • Platelet-Rich Plasma for Neurosurgery
    • Platelet-Rich Plasma for Other Surgeries

  • End User

    • Platelet-Rich Plasma Therapy in Hospitals
    • Platelet-Rich Plasma Therapy in Orthopedic Clinics
    • Platelet-Rich Plasma Therapy in Dermatology Clinics
    • Platelet-Rich Plasma Therapy by Other End Users

Key stakeholders in Market including industry players, policymakers, and investors in various countries have been continuously realigning their strategies and approaches to implement them in order to tap into new opportunities.

The Market survey of Platelet-Rich Plasma offers a comprehensive analysis of diverse features, including production capacities analysis of Platelet-Rich Plasma, demand, product developments, revenue generation, and Size of Platelet-Rich Plasma Market across the globe.

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=170

Some Notable Offerings by Fact.MR Report on Platelet-Rich Plasma market:

  • We will provide you an analysis of the extent to which this Platelet-Rich Plasma market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
  • We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
  • Also, this report will help you to identify any trends to forecast growth rates.
  • The analyzed report will forecast the general tendency for supply and demand.

Some of the Platelet-Rich Plasma Market insights and estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides: 

  • Details regarding latest innovations and development in Platelet-Rich Plasma and how it is gaining customer traction during the forecast period.
  • Analysis about the customer demand of the products and how it is likely to evolve in coming years.
  • Latest regulations enforced by government bodies and local agencies and their impact on Demand of Platelet-Rich Plasma Market .
  • Insights about adoption of new technologies and its influence on the Platelet-Rich Plasma market Size.
  • Overview of the impact of COVID-19 on Platelet-Rich Plasma Market and economic disruptions caused by the pandemic.
  • Evaluates post-pandemic impact on the Sales of Platelet-Rich Plasma Market during the forecast period.

To get all-in insights on the regional landscape of the Platelet-Rich Plasma Market, buy now:-https://www.factmr.com/checkout/170

After reading the Market insights of Platelet-Rich Plasma Report, readers can:

  • Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
  • Analyze key regions holding significant share of total Platelet-Rich Plasma market revenue.
  • Study the growth outlook of Platelet-Rich Plasma market scenario, including production, consumption, history and forecast.
  • Learn consumption pattern and impact of each end use & supply side analysis of Platelet-Rich Plasma market.
  • Investigate the recent R&D projects performed by each market player & competitive analysis of Platelet-Rich Plasma Market Players.

How Fact.MR Assists in Making Strategic Moves For Platelet-Rich Plasma Market Manufacturer?

  • The data provided in the Platelet-Rich Plasma market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
  • The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

Watch Trending Video on Hair Dye Market Survey Report by Fact.MR – https://www.youtube.com/watch?v=Ym42mK7wZWg

About Fact.MR:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

 Contact:

4-1-1 Nakano,
9F Nakano Sunplaza
Tokyo, 164-8512
Japan

Tel: +1 (888) 863-5616

s

Categories
Pharmaceutical

Demand For Ovarian Cancer Diagnostics To Rise At Robust CAGR Of Nearly 7% Over Next Ten Years

Fact.MR’s detailed study on the rapid medical diagnostic kits market forecasts the landscape to accrue significant gains through 2031. Rising prevalence of infectious diseases has been surging demand for rapid medical diagnostic kits, globally. Need for detecting new pathogens that are causing infections is boosting market growth. There has also been a noticeable decrease in the immune systems of people due to sedentary and unhealthy lifestyles, which makes them vulnerable to infections, thus, supplementing demand for rapid medical diagnostic kits.

Increasing geriatric population worldwide is also anticipated to aid market growth. Emergence of cheap rapid medical diagnostic kits, especially with the onset of the COVID-19 pandemic, is another factor catalyzing sales across regions. As per Fact.MR analysis, the global rapid medical diagnostic kits market is projected to expand at a steady CAGR of around 4% through 2031.

For detailed insights on enhancing your product footprint, request for a sample here-

https://www.factmr.com/connectus/sample?flag=S&rep_id=5584

 

Key Takeaways from Study

  • Blood glucose testing kits will remain the most-used over the long term, experiencing over two-fold growth through 2031.
  • North America to remain as a highly lucrative market; the region is witnessing high adopting these diagnostic kits to detect various infectious diseases caused by bacteria and viruses.
  • Europe to experience steady annual growth through 2031, driven by heightened investments to improve the condition of healthcare facilities.
  • Hospitals & clinics will continue to remain as the largest end-user segment demanding the highest volumes of rapid medical diagnostic kits.

Need more information about Report Methodology? Click here- 

https://www.factmr.com/connectus/sample?flag=RM&rep_id=5584

Key Market Segments

Considering the wide scope of the market, the report offers in-depth and segment-wise analysis and forecasts. The market is segmented into test, application, and region. This segment-wise analysis also provides a detailed country-wise forecast on all the key parameters of the market.

Test
  • Cholesterol Monitoring
  • Infectious Diseases Testing
  • Substance Abuse Testing
  • Fertility & Pregnancy Testing
  • Blood Glucose Testing
  • Other Tests
Application
  • Hospitals & Clinics
  • Homecare Settings
  • Veterinary
Region
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)


For comprehensive insights on this market adoption, ask an analyst here- 

https://www.factmr.com/connectus/sample?flag=AE&rep_id=5584

Prominent Market Drivers

  • Increasing prevalence of multidrug-resistant bacterial infections is set to propel demand for rapid medical testing.
  • Expanding population, genetic variation in hosts and pathogens, and environmental change are some other aspects contributing to increased demand for rapid medical testing, thereby boosting industry expansion.
  • Growing prevalence of chronic diseases is leading to an increase in the need for rapid disease diagnosis.

Market Competition

Key manufacturers profiled in Fact.MR’s report include Danaher Corporation, ACON Laboratories, Inc., Meridian Bioscience, Inc., Becton, Dickinson, and Company, Abbott Laboratories, Artron Laboratories Inc., Alfa Scientific Designs, Inc., BTNX, Inc., bioMérieux SA, Cardinal Health, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, McKesson Medical-Surgical, Inc., Trinity Biotech, and Zoetis, among others. Primary expansion strategies include acquisition of key distributors, collaborations, mergers, and product portfolio diversification.

More Valuable Insights

Fact.MR, in its new offering, brings to fore an unbiased analysis of the global rapid medical diagnostic kits market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges compelling insights on the market based on test (blood glucose testing, infectious disease testing, pregnancy and fertility testing, cholesterol monitoring, and other tests) and application (hospitals & clinics, homecare settings, and veterinary), across seven major regions of the world.

For More Insights: 

 https://www.biospace.com/article/andersen-tawil-syndrome-market-gains-ground-with-government-incentives-towards-rare-disease-treatments-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

4-1-1 Nakano,
9F Nakano Sunplaza
Tokyo, 164-8512
Japan

Tel: +1 (888) 863-5616

Categories
Pharmaceutical

Histopathology Testing Equipment Market Is Likely To Remain Positive In The Coming Future

Global sales of histopathology testing equipment surpassed US$ 5,300 Mn in 2017, with consumables leading the growth, according to the findings of a recently published study by Fact.MR.

Rising incidences of cancer and associated mortalities are driving the need for efficient tissue diagnosis. Moreover, growing inclination toward less-invasive diagnostic procedures for cancer and other malignancies drove growth of histopathology testing equipment.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=2240

“The American Cancer Society and National Center for Health Statistics have revealed that cancer cases in Unite States crossed 1,685,000 in 2017 and are likely to increase in the coming years. Likewise, according to WHO (World Health Organization) report, emerging economies such as India are witnessing an increase in cancer mortality rates with India reflecting 79 per 100,000 deaths. This has pushed the demand for efficient diagnosis of the disease, which is expected to translate into an increase in histopathology testing equipment sales crossing US$ 5,500 Mn by end of 2018”. –Lead Analyst, Fact.MR Medical Diagnostics Division

Consumables are likely to account for nearly 80% revenue share of the market, according to the report. Demand for instruments in the histopathology testing equipment market is projected to expand at a relatively slow pace compared to consumables, making them a lucrative area for manufacturers from an investment standpoint.

Reagents and Antibodies to Spearhead Growth of Histopathology Testing Equipment Market

Sales of consumables in the histopathology testing equipment market are estimated to be on an upswing in 2018, says the report. The growth in sales of consumables is largely attributed to the increasing demand for reagents and antibodies. Increasing use of reagents and kits in genomics, sequencing and diagnosis of chronic diseases remains instrumental in driving their sales worldwide. Fact.MR envisages that demand for reagents and antibodies is projected to expand at a significant rate of over 5.5 % in the coming years.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=2240

On this front, the report reveals that the demand for histopathology testing equipment across emerging economies in Asia Pacific such as China and India is projected to expand at a higher rate. According to United Nations, the number of aging population in India is expected to rise by 64 percent doing the 2015-2030 timeline, whereas China is likely to reflect a 71 percent increase in same time frame. This aspect continues to influence the use of histopathology testing equipment in a bid to reduce mortalities and facilitate health to the aged.

 

The demand for histopathology testing equipment for disease diagnosis applications is projected to expand at a stellar pace in the future. 2017 witnessed a positive spike in sales of histopathology testing equipment for disease diagnosis and the status quo is likely to continue in 2018 and ahead. Use of histopathology testing equipment in drug discovery is another field triggering the sales of histopathology testing equipment, in turn supporting growth of the overall histopathology testing equipment market, according to the report.

The outlook of the sales of histopathology testing equipment market is likely to remain positive in the future, with the market proceeding at a value CAGR of 4.8% throughout the 2018-2028 timeline.

Chapter 1 – Executive Summary

This chapter in the histopathology testing equipment market report includes overall histopathology testing equipment market overview, market analysis, analyst recommendations and wheel of fortune revealing opportunity assessment.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/2240

Chapter 2 – Market Introduction

The histopathology testing equipment market introduction covers detailed segmentation of the histopathology testing equipment market along with market definition.

Chapter 3 – Histopathology Testing Equipment Market Opportunity Analysis

This chapter in the histopathology testing equipment market report includes assessment on various macroeconomic factors impacting growth in sales of histopathology testing equipment. It also covers detailed opportunity analysis.

Chapter 4 – Market Background

This extensive chapter in the histopathology testing equipment market report covers market dynamics including drivers, trends and restraints that are influencing the growth of the overall histopathology testing equipment market. These dynamics are assessed across key regions in the globe.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/05/14/1823788/0/en/Smartphone-based-Pregnancy-Point-of-Care-Testing-Emerging-as-a-Potential-Alternative-to-Lab-based-Diagnostics-Fact-MR.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

4-1-1 Nakano,
9F Nakano Sunplaza
Tokyo, 164-8512
Japan

Tel: +1 (888) 863-5616